Brown Advisory Securities’s Regeneron Pharmaceuticals REGN Stock Holding History

Brown Advisory Securities’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,100	Closed	-$650K	–	107
2022 Q2	$650K	Sell	1,100 -329	-23%	-$214K	0.61%	44
2022 Q1	$998K	Hold	1,429	–	–	0.58%	40
2021 Q4	$903K	Hold	1,429	–	–	0.38%	61
2021 Q3	$865K	Hold	1,429	–	–	0.26%	85
2021 Q2	$798K	Hold	1,429	–	–	0.13%	112
2021 Q1	$676K	Hold	1,429	–	–	0.11%	122
2020 Q4	$690K	Hold	1,429	–	–	0.12%	115
2020 Q3	$800K	Sell	1,429 -805	-36%	-$488K	0.16%	91
2020 Q2	$1.43M	Hold	2,234	–	–	0.31%	60
2020 Q1	$1.13M	Hold	2,234	–	–	0.29%	66
2019 Q4	$839K	Hold	2,234	–	–	0.2%	96
2019 Q3	$619K	Hold	2,234	–	–	0.17%	113
2019 Q2	$699K	Hold	2,234	–	–	0.19%	110
2019 Q1	$917K	Sell	2,234 -35	-2%	-$14.4K	0.22%	99
2018 Q4	$843K	Sell	2,269 -41	-2%	-$15K	0.16%	125
2018 Q3	$933K	Sell	2,310 -5	-0.2%	-$1.9K	0.15%	135
2018 Q2	$797K	Sell	2,315 -1	-0%	-$313	0.14%	156
2018 Q1	$796K	Buy	+2,316	New	+$806K	0.15%	144

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brown Advisory Securities's REGN Position: Q3 2022 in Review

Brown Advisory Securities sold out of Regeneron Pharmaceuticals (REGN) in Q3 2022, closing a stake of 1,100 shares — an estimated $650K sold.

Brown Advisory Securities first reported a position in REGN in Q1 2018 and held it in 18 quarters. The position peaked at $1.43M in Q2 2020. 1,080 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

Brown Advisory Securities reported no remaining Regeneron Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Brown Advisory Securities sold 1,100 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $650K.
Brown Advisory Securities first reported a position in Regeneron Pharmaceuticals in Q1 2018 and held it in 18 quarters.
Brown Advisory Securities's Regeneron Pharmaceuticals position peaked at $1.43M in Q2 2020.
1,080 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on Brown Advisory Securities's 13F filing for Q3 2022, filed 14 Nov 2022.